CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
BBTI +2 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05419830
NCT05419830N/ACompleted

Sleep, Hypertension, and Nocturia: a Multicomponent Approach for Comorbid Illnesses

University of Pittsburgh·interventional·Posted Jun 15, 2022·Updated Dec 17, 2024

In Brief

A clinical study evaluating BBTI, PM antihypertensive dosing or Chronotherapy, and 1 other intervention for Nocturia and 2 related conditions. Completed, enrolled 30 participants across 1 site.

Detailed Summary

In this study the investigators target three common and comorbid illnesses among older adults namely nocturia or waking at night to void, poor sleep and hypertension. The aim of this proposal is to test behavioral sleep intervention to improve sleep and nocturia vs switching the time of antihypertensive administration to improve nighttime and in turn daytime blood pressure control.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2023202420252026
First PostedJun 15, 2022
Enrollment StartJun 1, 2022
Primary CompletionNov 30, 2023
Study CompletionJan 30, 2024
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 4.0 years ago

Interventions

BBTIbehavioral

Participants randomized to BBTI will receive 45- to 60-minute individual intervention session followed by a 30-minute follow-up session 2 weeks later, and 20-minute telephone calls after 1 and 3 weeks. BBTI will focus on four behaviors that promote sleep and discussion of homeostatic and circadian mechanisms of human sleep regulation. These four interventions are simple to conceptualize and implement, and constitute the core of efficacious multi-modal behavioral treatments for insomnia.

PM antihypertensive dosing or Chronotherapyother

participants will be asked to switch their conventional once daily non-diuretic antihypertensive to bedtime

AM antihypertensive dosingother

participants will be asked to continue taking their antihypertensive medication within an hour of awakening